Where Are the Sentinel Lymph Nodes Located?

Sentinel lymph nodes are not fixed to one spot in the body. A sentinel node is defined not by its address on an anatomy chart but by its function: it is the first lymph node to receive drainage directly from a tumor, making it the earliest place cancer cells would arrive if they began to spread through the lymphatic system.¹ That means sentinel node location depends entirely on where the primary cancer sits and which lymphatic channels drain that area. In breast cancer, the sentinel node is almost always in the armpit; in melanoma on the leg, it is usually in the groin. But the real picture is more varied than those textbook examples suggest, and surgeons regularly encounter sentinel nodes in places they did not expect.

Why There Is No Single Location

The concept of a sentinel node goes back to the 1970s, when a Paraguayan surgeon named Cabañas proposed that penile cancer drained first to a specific inguinal lymph node, and that checking this node could predict whether cancer had spread further.² The idea was later adapted for melanoma and breast cancer, turning into a widely used clinical technique by the 1990s.³ The original definition still holds: the sentinel node is the first node receiving lymphatic drainage from a primary tumor, and the concept reflects the idea that cancer spreads through lymphatic channels in an orderly, stepwise fashion.⁴

Because lymphatic anatomy varies from person to person and from tumor site to tumor site, the sentinel node can be anywhere along the drainage pathway. A tumor on the left side of the trunk might drain to the left armpit, to the left groin, or even to both. A cancer in the pelvis might drain to nodes in the iliac chain, the obturator region, or along the aorta. The location is discovered during each individual procedure, not assumed from a diagram.

Breast Cancer and the Axilla

For breast cancer, the sentinel node is found in the axilla (armpit) in the large majority of cases, specifically in levels I and II of the axillary lymph node basin. This makes intuitive sense because the breast’s lymphatic drainage overwhelmingly flows toward the armpit. But roughly one in five patients has a sentinel node that turns up somewhere else. A study of 113 breast cancer patients found that about 19 percent had sentinel nodes outside the standard axillary territory, most commonly in the internal mammary chain, a group of nodes running along the breastbone inside the chest wall.⁵ Internal mammary nodes are clinically important because they would be missed entirely by a standard axillary operation. If the sentinel node in a breast cancer patient drains to the internal mammary chain and that is the only site containing metastatic cells, the cancer would be understaged and potentially undertreated.

Melanoma and Unpredictable Drainage Patterns

Melanoma is perhaps the best illustration of how unpredictable sentinel node locations can be. A melanoma on the back of the shoulder might drain to the axilla, to the neck, or to both basins simultaneously. Trunk melanomas are especially prone to draining to more than one lymph node basin. Research comparing trunk and extremity melanomas found that roughly 31 percent of trunk melanomas drained to multiple basins, compared with about 7 percent of extremity melanomas.⁶

Beyond multiple basins, melanoma sentinel nodes sometimes show up in locations that fall entirely outside established node fields. A study of unusual sentinel node sites in cutaneous melanoma classified these as popliteal (behind the knee), epitrochlear (inside the elbow), or ectopic/interval nodes sitting in transit between the tumor and the nearest recognized basin. Among sentinel nodes at unusual sites, roughly three-quarters were ectopic or interval nodes, with the remainder split between the popliteal and epitrochlear regions.⁷ These nodes would not be found during a traditional node dissection aimed at one of the major basins, and they can be the only site of regional metastasis.

Mapping studies have identified several drainage pathways that contradict older textbook assumptions. Primaries on the upper back sometimes drain to sentinel nodes in the triangular intermuscular space, a spot between the muscles of the shoulder that few surgeons would think to check. Upper and lower back melanomas can drain to paraaortic or retroperitoneal nodes deep in the abdomen. And cancers near the belly button may drain along the costal margin to the internal mammary nodes inside the chest.⁸ Occasional drainage to lymph node basins on the opposite side of the body has also been documented from head, neck, and trunk primaries.

Trunk melanoma patients with drainage to multiple basins did present a question: does draining to two basins or to an unusual site worsen survival? The evidence suggests it does not. The study that documented the higher rate of multiple-basin drainage in trunk melanomas also found that neither multiple basins nor uncommon sentinel node locations affected overall survival.⁶

Oral and Head-and-Neck Cancers

In the head and neck, sentinel lymph nodes are typically found among the cervical lymph node levels (I through V), but the specific level depends heavily on where the primary tumor sits. A study exploring sentinel nodes from tumors of the tongue, floor of mouth, palate, retromolar area, and other oral sites found 124 sentinel nodes across 52 neck explorations, distributed across all five cervical levels. A handful turned up in unexpected positions: two in the tonsils, two in a deep cervical sublevel (IIB), four in level IV, one in level V, and three on the opposite side of the neck from the tumor.⁹ The clinical takeaway is that a standard surgical procedure targeting only the most common node levels would have missed several of these sentinel nodes.

Endometrial and Cervical Cancers

For endometrial cancer, the sentinel node sits in the pelvis in the vast majority of patients. Two consistent lymphatic pathways from the uterus have been identified: an upper paracervical pathway draining to medial external iliac and obturator nodes, and a lower paracervical pathway draining to internal iliac and presacral nodes.¹⁰

A multicenter study looking at the anatomical distribution of sentinel nodes in endometrial cancer found the external iliac region was the most common site, accounting for more than half of mapped nodes. The obturator area came second at about 23 percent, followed by the internal iliac, common iliac, paraaortic, and presacral regions in decreasing frequency.¹¹ In an earlier series of grade 1 endometrial cancers, about 89 percent of sentinel nodes were located within the standard pelvic lymph node dissection template, but the remaining fraction fell in the common iliac or paraaortic region, areas that would be missed if surgery stayed within the standard pelvic field.¹²

Prostate Cancer

Sentinel node mapping for prostate cancer tells a similarly wide-ranging story. A SPECT-based anatomic atlas of prostate sentinel nodes found the external iliac region was the most common location at about 34 percent, followed by the internal iliac region at about 18 percent, the common iliac at roughly 13 percent, and the sacral region at about 9 percent. Smaller fractions appeared in perirectal, paraaortic, deep inguinal, seminal vesicle, perivesical, and even superficial inguinal locations.¹³ The long tail of low-frequency locations highlights that roughly a third of prostate sentinel nodes sit outside the territory that would be covered by a standard pelvic lymph node dissection, which typically targets only the obturator and external iliac regions.

How Surgeons Find the Sentinel Node

Because the sentinel node’s location is unpredictable in advance, surgeons rely on real-time mapping during or just before the operation. The two traditional approaches are radiotracer injection and blue dye injection, and they are often used together.

For the radiotracer method, a small amount of a technetium-99m-labeled colloid is injected near the tumor. The tracer travels through the lymphatic channels and accumulates in the sentinel node, which can then be located with a handheld gamma probe in the operating room. Preoperative imaging (lymphoscintigraphy) shows the drainage pathway on a scan, revealing how many sentinel nodes exist and in which basins they sit.¹⁴ This imaging step is particularly valuable in melanoma, where drainage patterns are least predictable.

Blue dyes work differently. Isosulfan blue and patent blue bind to lymphatic proteins and get trapped in the vessels, physically staining the sentinel node a vivid blue that the surgeon can see with the naked eye. Methylene blue is a smaller molecule that does not bind plasma proteins but has shown comparable detection results to the other blue dyes.¹⁵ A prospective study in breast cancer found methylene blue successfully identified the sentinel node in 90 percent of patients.¹⁶

A newer option is indocyanine green (ICG), a fluorescent dye that glows under near-infrared light. ICG allows real-time visualization of lymphatic channels and nodes during surgery, without the radiation exposure or logistical hassle of a radiotracer.¹⁷ In some cases, surgeons can watch the dye traveling just beneath the skin in real time before making an incision.¹⁸ ICG is gaining traction but has not yet been broadly incorporated into international guidelines.

For gastrointestinal cancers like early gastric cancer, the same dual-tracer approach (dye plus radiotracer) has shown promise. A large prospective Japanese study found the method safe and effective for superficial and relatively small gastric tumors, and the concept of dissecting the sentinel node basin rather than performing a wide lymph node clearance has been proposed as a way to make surgery less invasive.¹⁹ Similarly, sentinel node mapping in colorectal cancer has been reported as highly successful and accurate, with a low rate of skip metastases.²⁰

Why Getting the Location Right Matters for You

The whole point of finding the sentinel node is to avoid removing large numbers of lymph nodes unnecessarily. In breast cancer, the alternative to sentinel node biopsy used to be axillary lymph node dissection, which strips out most of the nodes in the armpit. That procedure carries a substantial risk of lymphedema, a chronic swelling of the arm caused by disrupted lymphatic drainage. One study found lymphedema in about 27 percent of patients who had full axillary dissection, compared with roughly 3 percent of those who had only a sentinel node biopsy.²¹ That difference persists long-term: five years after surgery, sentinel node biopsy alone still resulted in significantly lower lymphedema rates.²² And the staging accuracy remained comparable, meaning surgeons were not sacrificing diagnostic quality to spare the patient a larger surgery.²³

When Previous Surgery Changes the Map

If you have already had surgery or radiation to the area around a lymph node basin, the lymphatic drainage can reroute itself. This is relevant for patients who develop a second cancer or a recurrence in a previously treated breast. In these patients, sentinel node mapping can still work, but the nodes may show up in entirely different locations. In one series, patients with a prior axillary lymph node dissection showed altered sentinel node distribution: some sentinel nodes turned up in the internal mammary chain on the same side, and others appeared in the contralateral (opposite-side) axilla.²⁴

Radiation therapy to the breast appears to be a particularly strong driver of this rerouting. One study found that contralateral axillary visualization occurred in seven of ten patients who had previous breast irradiation, regardless of whether they had also undergone axillary dissection.²⁵ Another study found that about 18 percent of patients with prior breast surgery showed aberrant drainage on repeat sentinel node mapping, and the tendency toward aberrant drainage was more frequent in the group that had undergone full axillary dissection.²⁶ The clinical lesson is straightforward: in a previously treated patient, do not assume the sentinel node is in the same basin it would normally be.

When the Sentinel Node Does Not Show Up

Sometimes, the tracer or dye does not reach any identifiable node. This non-visualization can happen when lymphatic vessels are blocked, either by tumor cells clogging the channels or by scar tissue from prior surgery or radiation. When that happens, the dye or radiotracer may take an alternative route and land in an uninvolved node instead, potentially producing a false-negative result: the biopsy declares the patient node-negative when cancer cells are actually trapped in a blocked, unmapped node.²⁷

The problem of non-visualization has been specifically documented in penile cancer. In one series, when a groin failed to show any sentinel node on imaging, surgeons explored those groins using blue dye and intraoperative palpation. They retrieved sentinel nodes in half of the non-visualized groins, and one of those nodes contained metastasis.²⁸ The finding underscores that a failure to visualize a sentinel node is not the same as the absence of lymph node disease, and it usually calls for further investigation rather than reassurance.

What Happens After the Node Is Removed

Once a sentinel node is taken out, it undergoes a more thorough examination than a lymph node in a standard dissection would receive. The limited number of sentinel nodes allows pathologists to slice and analyze each one more carefully, which increases the detection of very small deposits of cancer (micrometastases) that would be missed if dozens of nodes were processed in bulk. A key part of the examination is slicing the sentinel node no thicker than 2 mm and embedding the slices correctly. A single section prepared this way catches all deposits larger than 2 mm, but smaller metastases may still be missed without additional staining techniques like immunohistochemistry.²⁹ This concentrated scrutiny is one of the reasons sentinel node biopsy improved cancer staging: not just because surgeons were finding the right node, but because pathologists were examining it more carefully than they could manage with a large harvest of nodes.

Interval Nodes and In-Transit Disease in Melanoma

One category of sentinel node location that surprises clinicians is the interval node, sometimes called an in-transit node. These are nodes that sit along a lymphatic channel between the primary tumor and the nearest recognized lymph node basin. They are technically sentinel nodes by definition, since they receive drainage first, but they live outside any named node field. In melanoma studies, interval nodes made up the majority of “unusual site” sentinel nodes.⁷ They can appear in subcutaneous tissue of the flank, the back, or anywhere along the limb between the tumor and the axilla or groin. Without a radiotracer or dye guiding the surgeon, these would almost never be found on clinical examination or imaging. Their existence is one of the strongest arguments for performing formal sentinel node mapping rather than relying on anatomical assumptions about where lymph flows.

For trunk melanomas in particular, when multiple sentinel nodes are identified across different basins, it is not uncommon for only one basin to harbor a positive node while the other basins are clean. In one analysis of trunk melanoma patients who had sentinel nodes in two basins, only one case showed malignancy, and that positivity was confined to a single basin, not both.³⁰ The practical message is that finding multiple drainage basins does not mean the disease is more advanced; it just reflects the complexity of lymphatic anatomy in the trunk.